临床试验 for Cancer 治疗
研究题目:
S2104 - Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors推荐最近最火的赌博软件 Institutional Review Board (IRB) Number:
1947027研究/协议ID:
S2104研究阶段:
II患者年龄组别:
成年人Principal Investigator:
拉胡尔·赛斯，做吧What is involved if I participate?
- 研究持续多长时间?
5年 - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
No - What tests and procedures are involved?
Surgery, CTs and/or MRIs, Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP)
Where will the study take place?
推荐最近最火的赌博软件 University Hospital - Downtown Campus临床试验.政府 ID:
NCT05040360For more information about this trial go to 临床试验.政府
Who can I contact for more information?
名称: 阿米莉亚贝尔
电话: 315-464-5777
电子邮件: (电子邮件保护)